Viewing StudyNCT00040846



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00040846
Status: COMPLETED
Last Update Posted: 2020-01-29
First Post: 2002-07-08

Brief Title: Alemtuzumab Fludarabine Phosphate and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Organization Data

Organization: Fred Hutchinson Cancer Center
Class: OTHER
Study ID: 159100
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Fred Hutchinson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: Brenda Sandmaier
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Fred Hutchinson Cancer Center
Old Name: None
Old Organization: None

Collaborators

Name Class
National Heart Lung and Blood Institute NHLBI NIH
National Cancer Institute NCI NIH